Q98443513

Summary

Q98443513 is an interpellation^[1].

Key Facts

• Q98443513 authored Marita Aronson^[2].
• Q98443513's instance of is recorded as interpellation^[3].
• Q98443513's part of the series is recorded as interpellations of the 2003/04 legislative session of the Riksdag^[4].
• Q98443513's language of work or name is recorded as Swedish^[5].
• Q98443513 was published on +2004-02-19T00:00:00Z^[6].
• Q98443513's significant event is recorded as debate^[7].
• Q98443513's main subject is drug^[8].
• Q98443513's main subject is medication^[9].
• Q98443513's work available at URL is recorded as http://data.riksdagen.se/dokument/GR10311^[10].
• Q98443513's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GR10311^[11].
• Q98443513's applies to jurisdiction is recorded as Sweden^[12].
• Q98443513's legal citation of this text is recorded as ip. 2003/04:311^[13].
• Q98443513's title is recorded as medicinering med narkotikaklassade läkemedel^[14].
• Q98443513's addressee is recorded as Lars Engqvist^[15].
• Q98443513's maintained by WikiProject is recorded as Project Riksdagen's documents^[16].
• Q98443513's copyright status is recorded as public domain^[17].

Body

Definition and Type

Q98443513's instance of is recorded as interpellation^[3].